Phase 2 trial of encorafenib plus binimetinib for patients with BRAF V600 mutated relapsed/refractory hairy cell leukemia
Lacey James, Constance M. Yuan, Mark Raffeld, Robert J. Kreitman et al.
Journal
Blood
Topics
Chronic Lymphocytic Leukemia Research
article
Phase 2 trial of encorafenib plus binimetinib for patients with BRAF V600 mutated relapsed/refractory hairy cell leukemia
Lacey James, Constance M. Yuan, Mark Raffeld, Robert J. Kreitman, David Fernando Colón, Liqiang Xi, Katherine R. Calvo, Evgeny Arons, Hao‐Wei Wang, Elizabeth A. Holly, Hong Zhou, Irina Marić
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 146(Supplement 1)
Institutions
National Institutes of Health (US), Office of the Director (US), National Institutes of Health Clinical Center (US)